Company / Operating Cash Flow
EXACT SCIENCES CORP Operating Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
$491.4M
FY2025
5-year range
-$223.6M / $491.4M
FY2021-FY2025
Trend
+133.4%
vs FY2024
Sector context
#52 of 158
Health Care
What the data says
At $491M, EXACT SCIENCES CORP's operating cash flow ranks #52 of 158 in the Health Care sector. Operating Cash Flow has increased for 3 consecutive years, from -$224M in FY2022 to $491M in FY2025.
Based on SEC 10-K filings.
$491M in FY2025 with a 5-year CAGR of +29.2%.
Improved from $156M to $491M over the past 2 years.
Health Care sector context is included.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +29.2%
- 10-Year CAGR
- -
Sector benchmark
#52 of 158 in Health CareTop 33% of 158This company $491.4M Sector average $1.0B
▼
-52.4% below sector average
Key checks
Key Insights
- EXACT SCIENCES CORP's operating cash flow has grown for 3 consecutive years.
- 5-year CAGR of +29.2%, indicating consistent growth.
- In FY2025, operating cash flow increased 133.4% year-over-year.
- Ranks #52 out of 158 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $491.4M | +133.4% |
| FY2024 | $210.5M | +34.9% |
| FY2023 | $156.1M | +169.8% |
| FY2022 | -$223.6M | -118.7% |
| FY2021 | -$102.2M | -174.9% |
| FY2020 | $136.5M | +222.2% |
| FY2019 | -$111.7M | -62.0% |
| FY2018 | -$68.9M | +3.9% |
| FY2017 | -$71.7M | +44.9% |
| FY2016 | -$130.1M | +2.9% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026